Compassionate use of sitamaquine in an HIV-positive patient with visceral leishmaniasis

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 96, Issue 5, 2002, Pages 533-534

  Rashid, J R ^a   Nyakundi, P M ^a   Kirigi, G ^a   Kinoti, D ^a   Wasunna, M K ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

Chemotherapy; Co infection; Human immunodeficiency virus; Kenya; Leishmania sp.; Leishmaniasis; Sitamaquine

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; CD4 ANTIGEN; CLAVULANIC ACID; CLOXACILLIN; GENTAMICIN; MEFENAMIC ACID; MILTEFOSINE; PENICILLIN G; POVIDONE IODINE; SITAMAQUINE; STIBOGLUCONATE SODIUM;

ADULT; AMASTIGOTE; ANALGESIA; ARTICLE; BLOOD EXAMINATION; BONE MARROW BIOPSY; CASE REPORT; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KENYA; NEPHROTOXICITY; PHARYNGITIS; PNEUMONIA; REINFECTION; SUPERINFECTION; TH1 CELL; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIA SP.;

EID: 0036759649     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(02)90429-3     Document Type: Article

References (6)

1. Alvar, J., Cañavente, C., Gutiérrez-Solar, B., Jimenez, H., Laguna, F., Lopez-Velez, R., Molina, R. & Moreno, J. (1997). Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clinical Microbiology Reviews, 10, 298-319.
2. Dietze, R., Carvalho, S. F. G., Valli, L. C., Berman, J., Brewer, T., Milhous, W., Sanchez, J., Schuster, B. & Grogl, M. (2001). Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi. American Journal of Tropical Medicine and Hygiene, 65, 685-689
3. Herwaldt, B. L. (1999). Leishmaniasis. Lancet, 354, 1191-1199.
4. Murray, H. W. (1999). Kala-azar as an AIDS-related opportunistic infection. AIDS Patient Care and STDs, 13, 459-465.
5. Sherwood, J. A., Gachihi, G. S., Muigai, R. K., Skillman, D. R., Mugo, M., Rashid, J. R., Wasunna, K. M. A., Were, J. B. O., Kasili, S. K., Mbugua, J. M., Kirigi, G., Schaefer, K. U., Oster, C. N., Fleckenstein, L. L., Berman, J. D., Brewer, T. G., Roberts, C. R., Johnson, A. J. & Schuster, B. G. (1994). Phase 2 efficacy trial of an oral 8-aminoquinolone (WR6026) for treatment of visceral leishmaniasis. Clinical Infectious Diseases, 19, 1034-1039.
6. Thakur, C. P., Sinha P. K., Singh R. K., Hassan, S. M. & Narain, S. (2000). Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India. Transactions of the Royal Society of Topical Medicine and Hygiene, 94, 696-697.